One-stop clinics to make HIV prevention (PrEP) quicker and easier in Kenya
Simplifying PrEP delivery: One-stop service pathway to improve PrEP care efficiency and continuation in Kenya
This project tries giving all PrEP services in a single clinic visit so people at risk for HIV in Kenya can start and stay on prevention with less time and cost.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11126877 on NIH RePORTER |
What this research studies
If you use PrEP, long clinic visits with separate stops for testing, counseling, and pharmacy can be a big burden. This project provides all PrEP services in one room at public clinics in Kenya so visits are much quicker and simpler. The team will roll out the one-stop pathway across multiple clinics and track how many people start PrEP, continue using it, and how long they spend at the clinic. They will also measure costs and patient acceptability to see whether the approach helps people stay protected.
Who could benefit from this research
Good fit: HIV-negative adults and adolescents in Kenya who are at risk for HIV and interested in starting or continuing PrEP are the ideal candidates.
Not a fit: People who are already HIV-positive, not eligible for PrEP, unable to attend participating clinics, or who prefer the existing multi-stop clinic flow may not receive benefit from this project.
Why it matters
Potential benefit: If successful, this could make PrEP visits much faster and more affordable, helping more people start and continue HIV prevention and potentially reducing new infections.
How similar studies have performed: Previous work in Kenya showed public clinics can deliver PrEP with good uptake and a pilot of one-stop services cut wait times by over 80% and was highly acceptable to users and providers.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Mugwanya, Kenneth Kiggundu — University of Washington
- Study coordinator: Mugwanya, Kenneth Kiggundu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.